Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials
Abstract Background Although randomized controlled trials (RCTs) have suggested a non-significant increased risk of stroke among proton pump inhibitor (PPI) users, the association has not been confirmed. We evaluated the association between regular use of PPIs and incident stroke and identified popu...
Guardado en:
Autores principales: | Man Yang, Qiangsheng He, Fang Gao, Krish Nirantharakumar, Tonny Veenith, Xiwen Qin, Amy T. Page, Martin C. S. Wong, Junjie Huang, Zi Chong Kuo, Bin Xia, Changhua Zhang, Yulong He, Wenbo Meng, Jinqiu Yuan, Yihang Pan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44a52398f61e4a96a59955dad6a895f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay K, et al.
Publicado: (2015) -
SPECTRUM OF CULTURE POSITIVE HOSPITAL ACQUIRED PNEUMONIA IN PATIENTS RECEIVING PROTON PUMP INHIBITORS
por: Aaqib Jahangir Khan, et al.
Publicado: (2018) -
Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
por: Yifan Zeng, et al.
Publicado: (2021) -
Cost-effectiveness Analysis Comparing Vonoprazanbased Triple Therapy with Proton Pump Inhibitorbased Therapy in the Treatment of Helicobacter pylori Infection in Thailand
por: Jadesada Lertsirimunkong, et al.
Publicado: (2021) -
Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
por: Reuben Veysey-Smith, et al.
Publicado: (2021)